baxter international inc. Resources | BNET
On MovieTome: Guess who's the villain in IRON MAN 2?

BNET Industries

Baxter International Inc.

(BAX) is in the Health Care Industry

baxter international inc. - All News and Analysis

  • Revenue (Fiscal Year) $11.2B
  • Profit (Fiscal Year) $1.7B
  • Market Cap $33.4B
  • Incorporated: 1931
  • CEO: Mr. Robert L. Parkinson Jr.

Baxter International operates via three key business segments. Co.'s BioScience business produces recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as proteins used in hemostasis, wound-sealing and tissue regeneration; and vaccines. Meanwhile, Co.'s Medication Delivery business manufactures products used in the delivery of fluids and drugs to patients, and its Renal business provides products to treat end-stage renal disease, or irreversible kidney failure.

Stock Quote

Board of Directors

Mr. Robert L. Parkinson Jr. Chairman

Mr. Blake E. Devitt

Mr. John D. Forsyth

Ms. Gail D. Fosler

Ms. Carole J. Uhrich Shapazian

Mr. Thomas T. Stallkamp Lead Director

Dr. Wayne T. Hockmeyer Ph.D.

Dr. Joseph B. Martin M.D., Ph

Mr. Albert P.L. Stroucken

General Walter E. Boomer

Dr. James R. Gavin III, M.D

Mr. Peter S. Hellman

Mr. Kornelis J. Storm

Contact Information

One Baxter Parkway

Deerfield, IL

http://www.baxter.com

847 948-2000

NAICS Code

Surgical and Medical Instrument Manufacturing: 339112

advertisement
advertisement